Auto-Injector Contract Manufacturing Market Research Size Share Trend Global Demand by 2030 – Shanghaiist
The global auto-injector contract manufacturing market is expected to reach a size of 2.80 billion by 2030, growing at a compound annual growth rate of 10.4% over the forecast period compared to its current value of 1.16 billion in 2021. Auto-injectors are devices that allow the user to inject themselves. It is a key type of medical gadget that can deliver drugs to the patient intramuscularly or subcutaneously. They come with spring-fed prefilled syringes or cartridges. As medical equipment, auto-injectors typically deliver medication. Due to the many benefits associated with their use, medical professionals often use them. Compared to alternative techniques, an auto-injector is preferable because, among other benefits, it preserves the accuracy of drug dosing and reduces anxiety associated with needles. Due to increasing rates of anaphylaxis, growing need for specialty therapies, and increasing regulatory approvals, the auto-injector contract manufacturing market is growing. Rising incidence of diseases such as diabetes, rheumatoid arthritis, multiple sclerosis and others is the major factor propelling the growth of the auto-injectors market globally. The risk of developing rheumatoid arthritis increases with age, peaking between the ages of 35 and 50. Therefore, an increase in the number of people aged 65 and above is predicted to drive the growth of the international auto-injector contract manufacturing market. It is predicted that an increase in the number of injectable pharmaceuticals would be the main driver for the growth of the global market. Additionally, the use of new technologies is a significant factor expected to increase the global auto-injector contract manufacturing market. This growth is expected to occur over the next few years. Auto-injectors are being used more frequently owing to their portability, reduced likelihood of contracting an infection, and convenience of use, all of which have contributed to the expansion of the auto-injector market globally. Health care infrastructure is being updated by governments in developing countries, which is expected to expand access to health care through these efforts. It is expected that this would increase the demand for innovative forms of technology.
Request for sample pages:
Main Key Players
Phillips-Medisize (a Molex company) Elcam Drug Delivery Devices (E3D) (Elcam Medical) Jabil Healthcare Dali Medical Devices Ypsomed Delivery Systems (YDS) SHL Medical Haselmeier Owen Mumford Becton Dickinson and Company (BD) CCBio Nemera (Copernicus) Recipharm AB Sonceboz Solteam Medical Stevanato Group Union Medico ApS Neuma Engineering Emperra Eitan Medical Enable Injections West Pharmaceutical Services Inc Delfu Medical Wanhai Medical and other top player.
Do you have a specific question or requirement? Ask our industry expert:
Auto-Injector Contract Manufacturing Market Segmentation By Product • Disposable Auto-Injectors • Reusable Auto-Injectors • Portable Injector • Smart/Connected Auto-Injectors By Application • Anaphylaxis • Rheumatoid Arthritis • Multiple Sclerosis • Diabetes • Others By User final•Home care•Hospitals and clinics•Outpatient services
For more information :
InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market intelligence and competition to grow businesses. We help our clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in delivering syndicated and customized market intelligence reports with in-depth analysis with key market insights in a timely and cost effective manner.
InsightAce Analytics Pvt. ltd.
Such. : +1 551 226 6109
Email: [email protected]
Site visit: www.insightaceanalytic.com
Follow us on LinkedIn @ bit.ly/2tBXsgS